Astera Labs (ALAB) Insider Bethany Mayer Sells $271K of Stock
Astera Labs insider Bethany Mayer executed a planned sale of 686 shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Bethany Mayer sold 686 shares of Astera Labs, Inc. ($ALAB) at an average price of $395.04, worth about $270,998.67, on June 24, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.
Since the trade, $ALAB is up 7.7% after 1 week, down 27.1% after 1 month and down 28.5% to date (from the $399.92 close on Jun 24, 2026).
ALAB
Astera Labs, Inc.
Key Points
- Astera Labs insider Bethany Mayer sold 686 shares on June 24, 2026, at $395.04 each, totaling $270,998.67.
- Astera Labs, traded on NasdaqGS as ALAB, has a market cap of $67.15 billion and a P/E ratio of 266.5.
- Institutional investors like FMR LLC and BlackRock adjusted their Astera Labs holdings recently.
Get $ALAB trade alerts by text
We text you when insiders, Congress or big funds trade $ALAB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Astera Labs, Inc. alert may contain errors. Disclosures
On June 24, 2026, Bethany Mayer, an insider at Astera Labs, Inc. (NASDAQ:ALAB), sold 686 shares of the company at an average price of $395.04 per share. This planned transaction totaled approximately $270,998.67.
Insider Buying and Selling at Astera Labs, Inc.
Bethany Mayer's recent sale was part of a pre-arranged trading plan. Earlier in June, other insiders like Jack Lazar sold 10,000 shares at $355.17 each, while Craig Barratt and Michael Hurlston each bought 837 shares without a price attached, indicating internal confidence.
Other Institutional Activity in Astera Labs
FMR LLC increased its Astera Labs stake by 194,944 shares, bringing its total to 25,529,885 shares worth about $2.80 billion. Meanwhile, BlackRock trimmed its position by 1,519,089 shares, leaving it with 11,449,769 shares valued at $1.25 billion. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both initiated new positions, each acquiring over 6 million shares. Atreides Management, LP, more than doubled its stake with an addition of 1,754,593 shares, now holding 3,365,787 shares worth approximately $368.89 million.
Astera Labs, Inc. Stock Up 30.5%
As of Saturday, Astera Labs' stock traded near $379. The company boasts a market cap of $67.15 billion and a P/E ratio of 266.5, reflecting high investor expectations. With a beta of 3.963, the stock is quite volatile. Its 52-week range spans from $85.85 to $440.99, with a current 50-day moving average of $282.80 and a 200-day moving average of $191.42. The company's strong liquidity is evident with a current ratio of 11.3 and a quick ratio of 10.55.
Recent Earnings
Astera Labs reported revenue of about $1.00 billion, showing a growth rate of 93.4%. The company's net margin stands at 26.7%, with a return on equity of 21.1%. The next earnings release is scheduled for August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Analysts Set New Price Targets
On June 24, 2026, Stifel maintained a 'buy' rating on Astera Labs with a price target of $460. Other analysts, like B of A Securities, kept a 'hold' rating with a $450 target. The consensus among 22 analysts is a 'buy', with an average price target of $263.60.
About Astera Labs
Astera Labs, Inc. is a technology company based in San Jose, California. It specializes in semiconductor-based connectivity solutions for cloud and AI infrastructure. The company offers a range of products, including intelligent connectivity platforms and COSMOS software, serving hyperscalers and OEMs. Founded in 2017, it is led by CEO Mr. Jitendra Mohan and employs 756 people.
Bottom Line
Bethany Mayer's planned sale of Astera Labs shares is part of routine insider trading activity. Astera Labs remains a significant player in the semiconductor industry, with strong growth and institutional interest. Investors watch such insider activities closely, but it's essential to remember that these transactions don't necessarily indicate future stock performance.
Related Filing Alerts
Source: Bethany Mayer's Form 4 filing on $ALAB (Jun 24, 2026). Find the original filing: ALAB Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts